ClinicalTrials.Veeva

Menu

Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors (Microbio-siNET)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Enrolling

Conditions

Small-intestine Neuroendocrine Tumors

Treatments

Other: Blood and stool sampling

Study type

Observational

Funder types

Other

Identifiers

NCT06624865
2023-A02667-38 (Other Identifier)
69HCL23_1290

Details and patient eligibility

About

The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.

Enrollment

75 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with one or more small-intestine neuroendocrine tumor with indication of surgery
  • Patient with consent for the collection, storage and reuse of data associated with his/her disease
  • Age ≥ 18 years at the time of inclusion
  • Non-objection statement obtained for participation in the study

Exclusion criteria

  • Patients with poorly differentiated neuroendocrine carcinoma or NET (neuroendocrine tumors) of non-intestinal origin or mixed tumors (MiNEN)
  • Pregnant, parturient or breast-feeding women
  • Minors
  • Persons deprived of liberty by judicial or administrative decision
  • Adults under legal protection (guardianship, curatorship)

Trial design

75 participants in 1 patient group

patient with indication for small-intestine neuroendocrine tumor surgery
Description:
The target population for this study is consecutive patients with small-intestine neuroendocrine tumor for whom surgery is indicated
Treatment:
Other: Blood and stool sampling

Trial contacts and locations

1

Loading...

Central trial contact

Thomas WALTER, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems